{"pmid":32358580,"pmcid":"PMC7194244","title":"COVID-19: a case for inhibiting IL-17?","text":["COVID-19: a case for inhibiting IL-17?","Nat Rev Immunol","Pacha, Omar","Sallman, Mary Alice","Evans, Scott E","32358580"],"journal":"Nat Rev Immunol","authors":["Pacha, Omar","Sallman, Mary Alice","Evans, Scott E"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32358580","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1038/s41577-020-0328-z","topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138495342608384,"score":9.490897,"similar":[{"pmid":32339777,"pmcid":"PMC7175896","title":"May IL-17 have a role in COVID-19 infection?","text":["May IL-17 have a role in COVID-19 infection?","Med Hypotheses","Megna, Matteo","Napolitano, Maddalena","Fabbrocini, Gabriella","32339777"],"journal":"Med Hypotheses","authors":["Megna, Matteo","Napolitano, Maddalena","Fabbrocini, Gabriella"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32339777","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.mehy.2020.109749","topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138494189174787,"score":51.890316},{"pmid":32302707,"pmcid":"PMC7194796","title":"Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?","text":["Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?","Pharmacol Res","Casillo, Gian Marco","Mansour, Adel Abo","Raucci, Federica","Saviano, Anella","Mascolo, Nicola","Iqbal, Asif Jilani","Maione, Francesco","32302707"],"journal":"Pharmacol Res","authors":["Casillo, Gian Marco","Mansour, Adel Abo","Raucci, Federica","Saviano, Anella","Mascolo, Nicola","Iqbal, Asif Jilani","Maione, Francesco"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32302707","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.phrs.2020.104791","topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138494810980352,"score":42.26377},{"pmid":32353597,"pmcid":"PMC7185017","title":"SARS-COV2 INFECTION AND LUNG CANCER PATIENTS: the potential role of IL17 target therapy.","text":["SARS-COV2 INFECTION AND LUNG CANCER PATIENTS: the potential role of IL17 target therapy.","The coronavirus disease 2019 (Covid-19) outbreak is evolving rapidly worldwide. The Lung is the target organ of the primary infection and patient whit lung cancer seems to have a poor prognosis. This is the first reported investigation on a possible role of IL 17 target therapy in Lung Cancer patients with concomitant Sars-CoV2 infection.","J Thorac Oncol","Cafarotti, Stefano","32353597"],"abstract":["The coronavirus disease 2019 (Covid-19) outbreak is evolving rapidly worldwide. The Lung is the target organ of the primary infection and patient whit lung cancer seems to have a poor prognosis. This is the first reported investigation on a possible role of IL 17 target therapy in Lung Cancer patients with concomitant Sars-CoV2 infection."],"journal":"J Thorac Oncol","authors":["Cafarotti, Stefano"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32353597","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.jtho.2020.04.015","locations":["Lung Cancer"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138495654035458,"score":41.138985}]}